TEL-AVIV, Israel, Sept. 14, 2023 (GLOBE NEWSWIRE) — HUB Cyber Security Ltd (Nasdaq: HUBC), a developer of Confidential Computing cybersecurity solutions and services (“HUB Security” or the “Company”), announces a series of updates and initiatives aimed at further enhancing its commitment recovery of our positioning and value. Read more...
Read MoreBOSTON, Sept. 14, 2023 /PRNewswire/ — Sayata, the leading marketplace for insurance brokers and carriers to easily scale their SMB portfolios, added Manny Johl to the Carrier Relations department as Head of Partnerships. Read more...
Read MoreWILMINGTON, NC / ACCESSWIRE / September 14, 2023 / Apiture, a leading provider of digital banking solutions, today announced the introduction of family banking through a partnership with Greenlight® Financial Technology, Inc. (“Greenlight”), the fintech company on a mission to help parents raise financially smart kids. Through the Greenlight for Banks program, Greenlight’s family finance app is now available with Apiture’s Consumer Banking solution, providing banks and credit unions with a full suite of family banking tools to help improve financial literacy for the next generation. Read more...
Read MoreEarlier this month, McDonald’s added four new meatless products to its Netherlands range and, in a move to promote plant-forward food, listed them before beef on the menu. The new burgers, nuggets and salad join the Beyond Meat-based McPlant, which has been a permanent fixture on the fast-food chain’s Dutch menu since last year, after a successful trial the year before. Read...
Read MoreJERUSALEM, Sept. 14, 2023 — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that a patient with advanced inoperable pancreatic cancer has been treated in a clinical trial at Hadassah Medical Center in Jerusalem, Israel. The trial is designed for a broad range of solid tumor patients who do not qualify for participation in other existing trials or who do not have other treatment options according to the treating physician. Read...
Read More
